SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-004399
Filing Date
2024-04-01
Accepted
2024-03-29 17:35:56
Documents
19
Period of Report
2024-05-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A capr-20240514xdef14a.htm   iXBRL DEF 14A 858525
2 GRAPHIC capr-20240514xdef14a_a002.jpg GRAPHIC 8333
3 GRAPHIC capr-20240514xdef14a_a009.jpg GRAPHIC 31832
4 GRAPHIC capr-20240514xdef14a_a010.jpg GRAPHIC 31072
5 GRAPHIC capr-20240514xdef14a_bg001.jpg GRAPHIC 94748
6 GRAPHIC capr-20240514xdef14a_bg002.jpg GRAPHIC 177551
  Complete submission text file 0001558370-24-004399.txt   2336346

Data Files

Seq Description Document Type Size
7 EX-101.SCH capr-20240514.xsd EX-101.SCH 5771
8 EX-101.DEF capr-20240514_def.xml EX-101.DEF 6926
9 EX-101.LAB capr-20240514_lab.xml EX-101.LAB 14378
10 EX-101.PRE capr-20240514_pre.xml EX-101.PRE 7033
22 EXTRACTED XBRL INSTANCE DOCUMENT capr-20240514xdef14a_htm.xml XML 165719
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34058 | Film No.: 24804941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)